| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Basic Science Investigations |
Departments of Nuclear Medicine, Tracer Kinetics, Pathological Oncology, and Microbiology, Graduate School of Medicine, Hokkaido University, Sapporo; Department of Radiology, Nikko Memorial Hospital, Hokkaido; and Department of Radiology, Jichi Medical School, Tochigi, Japan
Although FDG uptake is closely related to the expression of the glucose transporter (GLUT) in malignant tumors, such a relationship has not been fully investigated in inflammatory lesions. The aim of our study was to determine the expression of GLUT subtypes in experimental inflammatory lesions and to compare the results with those in malignant tumors in relation to FDG accumulation. Methods: Rats were inoculated with a suspension of Staphylococcus aureus or allogenic hepatoma cells (KDH-8) into the left calf muscle. Five days after S. aureus inoculation (n = 9) and 14 d after KDH-8 inoculation (n = 11), [14C]FDG was injected intravenously and its accumulation in the infectious and tumor tissues was determined as the percentage activity of the injected dose per gram of tissue (%ID/g). The expression of glucose transporters (GLUT-1 to GLUT-5) was investigated by immunostaining the infectious tissues (n = 6) and the tumor tissues (n = 6). Immunohistochemical grading was assessed semiquantitatively by 5 observers. Results: The [14C]FDG uptake was significantly higher in the tumor lesion than in the inflammatory lesion (2.04 ± 0.38 %ID/g vs. 0.72 ± 0.15 %ID/g; P < 0.0001). The tumor and inflammatory tissues highly expressed GLUT-1 and GLUT-3. The GLUT-1 expression level was significantly higher in the tumor tissue than in the inflammatory tissue (P < 0.05). Conclusion: The results based on our models showed a high FDG uptake and high GLUT-1 expression level not only in the tumor lesion but also in the inflammatory lesion. The higher GLUT-1 expression level in the tumor lesion may partially explain the higher FDG accumulation in the tumor than in the inflammatory lesion.
Key Words: PET • glucose transporters • tumor • inflammation
This article has been cited by other articles:
|
|
 |
|
  S. L. Davis, E. L. Nuermberger, P. K. Um, C. Vidal, B. Jedynak, M. G. Pomper, W. R. Bishai, and S. K. Jain Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4879 - 4884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jadvar, A. Alavi, and S. S. Gambhir 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization J. Nucl. Med., November 1, 2009; 50(11): 1820 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Jacene, P. Ginsburg, J. Kwon, G. C. Nguyen, E. A. Montgomery, T. M. Bayless, and R. L. Wahl Prediction of the Need for Surgical Intervention in Obstructive Crohn's Disease by 18F-FDG PET/CT J. Nucl. Med., November 1, 2009; 50(11): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Chen, B.-F. Lee, W.-J. Yao, L. Cheng, P.-S. Wu, C. L. Chu, and N.-T. Chiu Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5 Am. J. Roentgenol., August 1, 2008; 191(2): 475 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mitsuoka, S. Miyoshi, Y. Kato, Y. Murakami, R. Utsumi, Y. Kubo, A. Noda, Y. Nakamura, S. Nishimura, and A. Tsuji Cancer Detection Using a PET Tracer, 11C-Glycylsarcosine, Targeted to H+/Peptide Transporter J. Nucl. Med., April 1, 2008; 49(4): 615 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meller, C.-O. Sahlmann, and A. K. Scheel 18F-FDG PET and PET/CT in Fever of Unknown Origin J. Nucl. Med., January 1, 2007; 48(1): 35 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhou, J. Kozlowski, A. L. Goodrich, N. Markman, D. L. Chen, and D. P. Schuster Molecular imaging of lung glucose uptake after endotoxin in mice Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L760 - L768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Love, M. B. Tomas, G. G. Tronco, and C. J. Palestro FDG PET of Infection and Inflammation RadioGraphics, September 1, 2005; 25(5): 1357 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Enhanced Apoptotic Reaction Correlates with Suppressed Tumor Glucose Utilization After Cytotoxic Chemotherapy: Use of 99mTc-Annexin V, 18F-FDG, and Histologic Evaluation J. Nucl. Med., May 1, 2005; 46(5): 794 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhao, Y. Kuge, T. Mochizuki, T. Takahashi, K. Nakada, M. Sato, T. Takei, and N. Tamaki Biologic Correlates of Intratumoral Heterogeneity in 18F-FDG Distribution with Regional Expression of Glucose Transporters and Hexokinase-II in Experimental Tumor J. Nucl. Med., April 1, 2005; 46(4): 675 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Brenner 18F-FDG PET in Rheumatoid Arthritis: There Still Is a Long Way to Go J. Nucl. Med., June 1, 2004; 45(6): 927 - 929. [Full Text] [PDF]
|
|
|
|
|
|
M. Henze, A. Mohammed, H. P. Schlemmer, K. K. Herfarth, S. Hoffner, S. Haufe, W. Mier, M. Eisenhut, J. Debus, and U. Haberkorn PET and SPECT for Detection of Tumor Progression in Irradiated Low-Grade Astrocytoma: A Receiver-Operating-Characteristic Analysis J. Nucl. Med., April 1, 2004; 45(4): 579 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Min, S. Biswal, C. Deroose, and S. S. Gambhir Tetraphenylphosphonium as a Novel Molecular Probe for Imaging Tumors J. Nucl. Med., April 1, 2004; 45(4): 636 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Chen and D. P. Schuster Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L834 - L840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Yen, L.-C. See, C.-H. Lai, C. W. Yah-Huei, K.-K. Ng, S.-Y. Ma, W.-J. Lin, J.-T. Chen, W.-J. Chen, C.-R. Lai, et al. 18F-FDG Uptake in Squamous Cell Carcinoma of the Cervix Is Correlated with Glucose Transporter 1 Expression J. Nucl. Med., January 1, 2004; 45(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-C. Yen, K.-K. Ng, S.-Y. Ma, H.-H. Chou, C.-S. Tsai, S. Hsueh, T.-C. Chang, J.-H. Hong, L.-C. See, W.-J. Lin, et al. Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3651 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mochizuki, Y. Kuge, S. Zhao, E. Tsukamoto, M. Hosokawa, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V J. Nucl. Med., January 1, 2003; 44(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
